Michael Buckstein
Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center
Papers
2
Total Citations
30
H-Index
2
About
Michael Buckstein is a radiation oncologist whose research focuses on optimizing treatment sequencing and outcomes for gastrointestinal and head and neck cancers. His work has provided critical insights into surgical and adjuvant therapy strategies, particularly for gastric adenocarcinoma and oropharyngeal carcinoma. In a landmark 2017 study (16 citations), Buckstein identified key predictors of positive margins after definitive resection for gastric cancer, demonstrating how this finding can guide the use of adjuvant therapies to improve patient prognosis. Earlier, in 2014 (14 citations), he investigated the impact of transoral robotic surgery (TORS) on adjuvant radiation therapy for head and neck cancer, showing that faster postoperative recovery with TORS can significantly shorten the overall treatment package time, thereby reducing toxicity and improving outcomes. These contributions have helped shape clinical decision-making around surgical margins and the timing of radiotherapy, directly influencing patient care. Buckstein’s work is widely cited for its practical implications in multidisciplinary oncology, and he continues to advance the field through research that bridges surgery and radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2